<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="3286">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04340414</url>
  </required_header>
  <id_info>
    <org_study_id>Low flow-ECMO by CVVH in NCP</org_study_id>
    <nct_id>NCT04340414</nct_id>
  </id_info>
  <brief_title>Safety and Effectiveness of Low-flow ECMO Driving by CVVH Machine in Severe NCP</brief_title>
  <official_title>Safety and Effectiveness Study of Low Flow Extracorporeal Membrane Oxygenation（CO2 Removal） Driving by Continuous Hemofiltration Machine the Severe New Corovirus Pneumonia (NCP)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking Union Medical College Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking Union Medical College Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      assess the safety and effectiveness of using low-flow extracorporeal membrane oxygenation(CO2
      removal) driving by CVVH machine in the severe NCP patients
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 20, 2020</start_date>
  <completion_date type="Anticipated">October 15, 2020</completion_date>
  <primary_completion_date type="Anticipated">August 15, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>PaCO2</measure>
    <time_frame>Day 1</time_frame>
    <description>PaCO2 from blood gas analysis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Driving Pressure</measure>
    <time_frame>Day 1</time_frame>
    <description>Driving Pressure monitor by ventilator</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Tidal volume</measure>
    <time_frame>Day 1</time_frame>
    <description>Tidal volume monitor by ventilator</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>COVID-19</condition>
  <condition>ECMO</condition>
  <arm_group>
    <arm_group_label>NCP patient with severe ARDS and/or high ventilator supported</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The NCP patient with severe ARDS and/or high ventilator supported condition was eligibilitable for enrollment</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Low flow ECMO driving by CVVH machine</intervention_name>
    <description>With aim to clear CO2 and improve oxygenation, a low flow ECMO treatment(using oxgyenator membrane of kid type ) driving by CVVH machine will be performed in the NCP with severe ARDS</description>
    <arm_group_label>NCP patient with severe ARDS and/or high ventilator supported</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  1. NCP with severe acute respiratory distress syndrome with ratio of partial pressure
             of arterial oxygen over fraction of inspired oxygen (PaO2:FiO2)&lt;150 and PEEP &gt;10cmH2O

          -  2. Driving pressure&gt; 20cmH2O

          -  3. RR&gt;30bpm

          -  4.PaCO2&gt;55cmH2O and/or PH&gt;7.3

        Exclusion Criteria:

          -  1. poor venous vascular condition and unavaible for central venous catheter placement
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yun Long</last_name>
    <role>Principal Investigator</role>
    <affiliation>Peking Union Medical College Hospit</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yun Long, MD</last_name>
    <phone>+8610169152300</phone>
    <email>ly_icu@aliyun.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yun Long</last_name>
    <phone>+8610169152300</phone>
    <email>ly_icu@aliyun.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Yun Long</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100730</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yun Long</last_name>
      <phone>+8610169152300</phone>
      <email>ly_icu@aliyun.com</email>
    </contact>
    <investigator>
      <last_name>Xiang Zhou, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Huaiwu He, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Wei Cheng, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>March 3, 2020</study_first_submitted>
  <study_first_submitted_qc>April 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 9, 2020</study_first_posted>
  <last_update_submitted>June 13, 2020</last_update_submitted>
  <last_update_submitted_qc>June 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

